
Results
62
62 companies
Incyte
Market Cap: US$24.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$121.07
7D
0.4%
1Y
48.4%
Exelixis
Market Cap: US$13.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$51.33
7D
-8.3%
1Y
35.3%
Orion Oyj
Market Cap: €11.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.35
7D
-1.3%
1Y
19.2%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥53.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥117.31
7D
5.6%
1Y
30.9%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥42.9b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥46.79
7D
8.9%
1Y
33.0%
Abbott India
Market Cap: ₹595.2b
Operates as a pharmaceutical company in India.
500488
₹28,146.90
7D
1.5%
1Y
-14.7%
3SBio
Market Cap: HK$44.3b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.62
7D
2.3%
1Y
-43.3%
ACADIA Pharmaceuticals
Market Cap: US$5.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$29.41
7D
8.3%
1Y
15.6%
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩88,350.00
7D
7.7%
1Y
-11.8%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥31.9b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥119.90
7D
8.7%
1Y
6.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹439.9b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,619.65
7D
2.1%
1Y
-5.6%
Ajanta Pharma
Market Cap: ₹438.0b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,541.00
7D
3.0%
1Y
32.5%
Sumitomo Pharma
Market Cap: JP¥603.4b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,348.00
7D
5.9%
1Y
-3.0%
Xiamen Amoytop Biotech
Market Cap: CN¥24.7b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.36
7D
3.1%
1Y
-31.8%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥24.7b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥36.72
7D
-1.6%
1Y
-14.1%
Zealand Pharma
Market Cap: DKK 23.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 335.10
7D
5.3%
1Y
-2.3%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.35
7D
-1.0%
1Y
7.9%
Neuland Laboratories
Market Cap: ₹294.5b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹22,505.60
7D
12.7%
1Y
72.9%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س9.8b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س141.90
7D
-0.07%
1Y
-11.9%
CareDx
Market Cap: US$2.4b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$47.23
7D
0.3%
1Y
279.1%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥15.4b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.19
7D
-0.1%
1Y
-4.9%
ADMA Biologics
Market Cap: US$2.2b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$9.91
7D
11.2%
1Y
-40.9%
HBM Holdings
Market Cap: HK$13.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$15.03
7D
19.2%
1Y
33.5%
Innoviva
Market Cap: US$1.5b
Operates as a biopharmaceutical company in the United States and internationally.
INVA
US$20.75
7D
-0.5%
1Y
3.3%
CORONA Remedies
Market Cap: ₹128.5b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,135.90
7D
1.9%
1Y
n/a
ChemoMetec
Market Cap: DKK 8.3b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 475.00
7D
13.9%
1Y
-5.4%
BioGaia
Market Cap: SEK 11.4b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 112.20
7D
-1.6%
1Y
19.8%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,800.00
7D
15.5%
1Y
15.0%
Soho Global Health
Market Cap: Rp15.0t
Together with its subsidiaires, operates as a healthcare company in Indonesia.
SOHO
Rp1,180.00
7D
-1.3%
1Y
56.3%
Zevra Therapeutics
Market Cap: US$681.7m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.34
7D
7.8%
1Y
-3.6%
CorMedix
Market Cap: US$590.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.30
7D
-2.9%
1Y
-36.5%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.1b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س60.35
7D
2.6%
1Y
-13.1%
Rafa Laboratories
Market Cap: ₪1.5b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪15.65
7D
-2.2%
1Y
n/a
Onconic Therapeutics
Market Cap: ₩674.3b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩15,800.00
7D
21.3%
1Y
156.4%
DHG Pharmaceutical
Market Cap: ₫12.5t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫95,600.00
7D
0.8%
1Y
-6.8%
Q32 Bio
Market Cap: US$466.5m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$15.41
7D
-4.6%
1Y
817.3%